NBY has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
NovaBay Pharmaceuticals Inc's quarterly cash and cash equivalents declined from Dec. 2013 ($10.50 Mil) to Mar. 2014 ($10.32 Mil) and declined from Mar. 2014 ($10.32 Mil) to Jun. 2014 ($7.76 Mil).
NovaBay Pharmaceuticals Inc's annual cash and cash equivalents increased from Dec. 2011 ($8.43 Mil) to Dec. 2012 ($12.74 Mil) but then declined from Dec. 2012 ($12.74 Mil) to Dec. 2013 ($10.50 Mil).
Cash and cash equivalents on banks book.
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
NovaBay Pharmaceuticals Inc Annual Data
NovaBay Pharmaceuticals Inc Quarterly Data